AZARGA

This brand name is authorized in Australia, Austria, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Nigeria, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug AZARGA contains a combination of these active pharmaceutical ingredients (APIs):

1	Brinzolamide UNII 9451Z89515 - BRINZOLAMIDE
	Brinzolamide is an inhibitor of carbonic anhydrase II (CA-II). Carbonic anhydrase (CA) is an enzyme found in many tissues of the body, including the eye. Inhibition of carbonic anhydrase in the ciliary processes of the eye decreases aqueous humour secretion resulting in a reduction in intraocular pressure (IOP) which is a major risk factor in the pathogenesis of optic nerve damage and glaucomatous visual field loss.
	Read more about Brinzolamide
2	Timolol UNII P8Y54F701R - TIMOLOL MALEATE
	Timolol is a non-selective beta-adrenergic receptor blocking agent that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anaesthetic activity. Timolol reduces intra-ocular pressure, whether or not this is associated with glaucoma.
	Read more about Timolol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01ED51	Timolol, combinations	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01ED Beta blocking agents
Discover more medicines within S01ED51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	3438Y, 5562R
CA	Health Products and Food Branch	02331624
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00672188, 00672194, 05481004, 05749547, 05749553, 05885718, 05885724, 06116264, 06330253, 06330276, 07776910, 10931171, 11079246, 11667960, 11667977, 16002610, 16840417, 16939759
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	29335-08-10
EE	Ravimiamet	1392207, 1392218
ES	Centro de información online de medicamentos de la AEMPS	08482001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	027202, 027214
FR	Base de données publique des médicaments	65711858
GB	Medicines & Healthcare Products Regulatory Agency	154543, 180517, 185461, 374301, 376211, 379797
HK	Department of Health Drug Office	58563
IE	Health Products Regulatory Authority	13112, 53502, 53551, 53565
IL	מִשְׂרַד הַבְּרִיאוּת	6792
IT	Agenzia del Farmaco	038837011
LT	Valstybinė vaistų kontrolės tarnyba	1005525, 1035363
NG	Registered Drug Product Database	B4-5549
Switch country to Nigeria in order to find specific presentations of AZARGA
NL	Z-Index G-Standaard, PRK	88552
NZ	Medicines and Medical Devices Safety Authority	13770
PL	Rejestru Produktów Leczniczych	100201818
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64501001, W64501002
SG	Health Sciences Authority	13802P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699504710106
ZA	Health Products Regulatory Authority	44/15.4/0046